Cathryn Nagler graduated with honors from Barnard College, Columbia University. She obtained her Ph.D. from the Sackler Institute of Biomedical Science at N.Y.U. School of Medicine and did a postdoctoral fellowship at M.I.T. She was Associate Professor of Pediatrics (Immunology) at Harvard Medical School prior to joining the University of Chicago in 2009. She received the inaugural Bunning Food Allergy Professorship in 2011. Dr. Nagler has participated in numerous review panels for the Crohn’s and Colitis Foundation of America, NIDDK, NIAID, and Food Allergy Research and Education (FARE). She recently began her second term on FARE’s research advisory board. She has served the American Association of Immunologists (AAI) as Section Editor for the Journal of Immunology, Instructor (Mucosal Immunology) for the Introduction to Immunology course and as member of the Program, Clinical Immunology, Publications and Awards Committees. She is the senior editor for Clinical and Translational Immunology for the AAI’s new journal ImmunoHorizons. She has also served as an elected Councilor of the Society for Mucosal Immunology and is an Associate Editor of the journal Mucosal Immunology. Dr. Nagler has a long-standing interest in the mechanisms governing tolerance to dietary antigens and the potential immunomodulatory features of the oral route of antigen administration. Her most recent work examines how commensal bacteria regulate susceptibility to allergic responses to food. She has applied insights gained from studying pre-clinical gnotobiotic murine models of cow’s milk allergy to launch a new company, ClostraBio, which is developing microbiome-modulating therapeutics for the prevention and treatment of food allergy.